Noronha Vanita, Kolkur Manali, Haridas Chinmay, Bhagyavant Priyanka, Das Richa, Chittari Shrusti Sagaraih, Vasudevan Lakshanya, Bafna Gunj, Menon Nandini, Shah Minit, Prabhash Kumar
Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai 400012, India.
Department of Medicine, Shri Vasantrao Naik Government Medical College, Yavatmal 445001, India.
Ecancermedicalscience. 2024 Sep 5;18:1755. doi: 10.3332/ecancer.2024.1755. eCollection 2024.
Despite an increasing number of female oncologists, disparities persist in authorship representation of women, especially in high-impact journals.
This study aimed to investigate gender differences in authorship within select high-impact Indian oncology journals over a 5-year period, assessing trends in the gender gap.
Six high-impact Indian oncology journals were selected for analysis. Data on original articles, reviews and editorials published between 2017 and 2022 were collected, including authors' gender, their role as first author or corresponding author and name of the journal. Gender determination was validated through web searches. Descriptive statistics were used to summarize the data and to study the prevalence of female authorship across journals.
A total of 2,235 articles were included. Across all journals, 30.4% of authors were female, with Journal of Cancer Research and Treatment exhibiting the highest proportion of female authors (948/2,507; 37.8%). Female authorship increased over time, with first authors rising from 33% to 41%, and corresponding authors from 29.4% to 36.4%. However, disparities persisted, and certain journals exhibited fluctuating trends. Female authorship was higher in original articles (30.9%) compared to reviews (27.8%) and editorials (24.5%). Women comprised 3.5%-24.4% of the editorial boards of the six journals.
Female representation, both as authors and editorial board members of Indian oncology journals is disproportionately low. Proactive measures are necessary to address these disparities and promote gender equity in academic publishing.
尽管女性肿瘤学家的数量不断增加，但在作者署名方面，女性的代表性仍然存在差异，尤其是在高影响力期刊中。
本研究旨在调查印度高影响力肿瘤学期刊在5年期间作者署名的性别差异，评估性别差距的趋势。
选择6种高影响力的印度肿瘤学期刊进行分析。收集2017年至2022年发表的原创文章、综述和社论的数据，包括作者性别、第一作者或通讯作者的角色以及期刊名称。通过网络搜索验证性别判定。使用描述性统计来汇总数据并研究各期刊女性作者的比例。
共纳入2235篇文章。在所有期刊中，30.4%的作者为女性，《癌症研究与治疗杂志》的女性作者比例最高（948/2507；37.8%）。女性作者比例随时间增加，第一作者从33%升至41%，通讯作者从29.4%升至36.4%。然而，差异仍然存在，某些期刊呈现波动趋势。原创文章中的女性作者比例（30.9%）高于综述（27.8%）和社论（24.5%）。女性占六种期刊编辑委员会成员的3.5%-24.4%。
印度肿瘤学期刊的作者和编辑委员会成员中女性的代表性极低。需要采取积极措施来解决这些差异，促进学术出版中的性别平等。
